However, the partially abolished R5 inhibition efficacy on cell migration and invasion that occurs with TGF-β1 treatment suggests that specific blocking of Slit2/Robo1 signaling to inhibit tumor metastasis using R5 could also target other signaling pathways, at least including activation of Hakai-mediated EMT [8]. This evidence concerns the gene CBLL1 and neoplasm.